Shawn M. Bowman - Dec 2, 2022 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)

Signature
/s/ Shawn M. Bowman
Stock symbol
SMTI
Transactions as of
Dec 2, 2022
Transactions value $
-$86,767
Form type
4
Date filed
12/6/2022, 05:33 PM
Previous filing
Sep 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMTI Common Stock Tax liability -$37.7K -1.22K -6.6% $30.79 17.3K Dec 2, 2022 Direct F1
transaction SMTI Common Stock Tax liability -$40.6K -1.1K -6.35% $36.86 16.2K Dec 2, 2022 Direct F2
transaction SMTI Common Stock Tax liability -$2.52K -82 -0.51% $30.79 16.1K Dec 2, 2022 Direct F3
transaction SMTI Common Stock Tax liability -$5.97K -260 -1.61% $22.97 15.9K Dec 2, 2022 Direct F4
transaction SMTI Common Stock Disposed to Issuer $0 -4.41K -27.79% $0.00 11.5K Dec 2, 2022 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,022 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
F2 Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
F3 Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 334 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
F4 Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,065 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
F5 Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated, and forfeited by the reporting person in connection with his resignation as President, Strategic Partnerships, effective December 2, 2022.